Ameren (AEE) Financials

$98.51 -0.46 (-0.46%)

As of 05/20/2025 03:59 PM Eastern

Annual Income Statements for Ameren

This table shows Ameren's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	1,182	1,152	1,074	990	871	828	815	523	653	630
Consolidated Net Income / (Loss)	1,187	1,157	1,079	995	877	834	821	529	659	636
Net Income / (Loss) Continuing Operations	1,187	1,157	1,079	995	877	834	821	529	659	585
Total Pre-Tax Income	1,270	1,340	1,255	1,152	1,032	1,016	1,058	1,105	1,041	948
Total Operating Income	1,516	1,558	1,515	1,333	1,300	1,267	1,357	1,410	1,322	1,259
Total Gross Profit	3,653	3,467	3,343	2,991	2,858	2,743	2,795	2,783	2,634	2,597
Total Revenue	7,623	7,500	7,957	6,394	5,794	5,910	6,291	6,174	6,076	6,098
Operating Revenue	7,623	7,500	7,957	6,394	5,794	5,910	6,291	6,174	6,076	6,098
Total Cost of Revenue	3,970	4,033	4,614	3,403	2,936	3,167	3,496	3,391	3,442	3,501
Operating Cost of Revenue	3,970	4,033	4,614	3,403	2,936	3,167	3,496	3,391	3,442	3,501
Total Operating Expenses	2,137	1,909	1,828	1,658	1,558	1,476	1,438	1,373	1,312	1,338
Depreciation Expense	1,590	1,387	1,289	1,146	1,075	995	955	896	845	796
Other Operating Expenses / (Income)	547	522	539	512	483	481	483	477	467	473
Total Other Income / (Expense), net	-246	-218	-260	-181	-268	-251	-299	-305	-281	-311
Interest Expense	663	566	486	383	419	381	401	391	382	355
Other Income / (Expense), net	417	348	226	202	151	130	102	86	101	44
Income Tax Expense	83	183	176	157	155	182	237	576	382	363
Net Income / (Loss) Attributable to Noncontrolling Interest	5.00	5.00	5.00	5.00	6.00	6.00	6.00	6.00	6.00	6.00
Basic Earnings per Share	$4.43	$4.39	$4.16	$3.86	$3.53	$3.37	$3.34	$2.16	$2.69	$2.60
Weighted Average Basic Shares Outstanding	266.80M	262.80M	258.40M	256.30M	247M	245.60M	243.80M	242.60M	242.60M	242.60M
Diluted Earnings per Share	$4.42	$4.38	$4.14	$3.84	$3.50	$3.35	$3.32	$2.14	$2.68	$2.59
Weighted Average Diluted Shares Outstanding	267.40M	263.40M	259.50M	257.60M	248.70M	247.10M	245.80M	244.20M	243.40M	243.60M
Weighted Average Basic & Diluted Shares Outstanding	397.48M	393.87M	389.60M	385.30M	380.93M	373.81M	372.22M	370.21M	242.80M	244.60M
Cash Dividends to Common per Share	$2.68	$2.52	$2.36	$2.20	$2.00	$1.92	$1.85	$1.78	$1.72	$1.66

This table shows Ameren's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	289	207	456	258	261	158	493	237	264	163	452
Consolidated Net Income / (Loss)	290	208	457	260	262	159	494	239	265	164	453
Net Income / (Loss) Continuing Operations	290	208	457	260	262	159	494	239	265	164	453
Total Pre-Tax Income	340	151	514	299	306	198	563	277	302	192	531
Total Operating Income	430	198	586	361	371	264	614	329	351	276	599
Total Gross Profit	941	794	1,124	868	867	751	1,130	788	798	724	1,093
Total Revenue	2,097	1,941	2,173	1,693	1,816	1,618	2,060	1,760	2,062	2,046	2,306
Operating Revenue	2,097	1,941	2,173	1,693	1,816	1,618	2,060	1,760	2,062	2,046	2,306
Total Cost of Revenue	1,156	1,147	1,049	825	949	867	930	972	1,264	1,322	1,213
Operating Cost of Revenue	1,156	1,147	1,049	825	949	867	930	972	1,264	1,322	1,213
Total Operating Expenses	511	596	538	507	496	487	516	459	447	448	494
Depreciation Expense	367	465	388	376	361	363	369	335	320	324	350
Other Operating Expenses / (Income)	144	131	150	131	135	124	147	124	127	124	144
Total Other Income / (Expense), net	-90	-47	-72	-62	-65	-66	-51	-52	-49	-84	-68
Interest Expense	175	171	173	165	154	153	152	134	127	130	126
Other Income / (Expense), net	85	124	101	103	89	87	101	82	78	46	58
Income Tax Expense	50	-57	57	39	44	39	69	38	37	28	78
Net Income / (Loss) Attributable to Noncontrolling Interest	1.00	1.00	1.00	2.00	1.00	1.00	1.00	2.00	1.00	1.00	1.00
Basic Earnings per Share	$1.07	$0.77	$1.71	$0.97	$0.98	$0.60	$1.88	$0.90	$1.01	$0.63	$1.75
Weighted Average Basic Shares Outstanding	270M	266.80M	266.80M	266.70M	266.40M	262.80M	262.80M	262.60M	262.20M	258.40M	258.40M
Diluted Earnings per Share	$1.07	$0.77	$1.70	$0.97	$0.98	$0.61	$1.87	$0.90	$1.00	$0.63	$1.74
Weighted Average Diluted Shares Outstanding	271.40M	267.40M	267.30M	266.80M	266.80M	263.40M	263.40M	263.20M	263.10M	259.50M	259.50M
Weighted Average Basic & Diluted Shares Outstanding	397.86M	397.48M	394.50M	394.39M	394.25M	393.87M	390.52M	390.33M	390.19M	389.60M	386.10M
Cash Dividends to Common per Share	$0.71	-	$0.67	$0.67	$0.67	-	$0.63	$0.63	$0.63	-	$0.59

This table details how cash moves in and out of Ameren's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	56	56	61	-297	125	69	39	16	-299	287
Net Cash From Operating Activities	2,763	2,564	2,263	3,252	1,727	2,170	2,170	2,118	2,117	2,031
Net Cash From Continuing Operating Activities	2,763	2,564	2,263	3,252	1,727	2,170	2,170	2,118	2,117	2,035
Net Income / (Loss) Continuing Operations	1,187	1,157	1,079	1,943	877	834	821	529	659	585
Consolidated Net Income / (Loss)	1,187	1,157	1,079	1,943	877	834	821	529	659	636
Depreciation Expense	1,524	1,432	1,373	2,394	1,153	1,002	938	876	835	777
Amortization Expense	100	84	86	158	22	98	115	98	110	119
Non-Cash Adjustments To Reconcile Net Income	39	-12	49	-16	11	-22	28	-17	-6.00	53
Changes in Operating Assets and Liabilities, net	-87	-97	-324	-1,227	-336	258	268	632	519	501
Net Cash From Investing Activities	-4,456	-3,798	-3,370	-6,887	-3,329	-2,435	-2,336	-2,204	-2,158	-1,976
Net Cash From Continuing Investing Activities	-4,456	-3,798	-3,370	-6,887	-3,329	-2,435	-2,336	-2,204	-2,158	-1,951
Purchase of Property, Plant & Equipment	-4,319	-3,597	-3,351	-6,926	-3,233	-2,411	-2,286	-2,132	-2,076	-1,917
Purchase of Investments	-584	-266	-229	-904	-224	-463	-315	-321	-322	-363
Sale and/or Maturity of Investments	564	240	216	878	183	467	299	305	304	349
Other Investing Activities, net	-117	-175	-6.00	65	-55	-28	-34	-56	-64	-20
Net Cash From Financing Activities	1,749	1,290	1,168	3,338	1,727	334	205	102	-258	232
Net Cash From Continuing Financing Activities	1,749	1,290	1,168	3,338	1,727	334	205	102	-258	232
Repayment of Debt	-939	-131	-523	-90	-462	-597	-857	-693	-397	-533
Payment of Dividends	-719	-667	-615	-599	-500	-478	-457	-437	-422	-408
Issuance of Debt	3,142	1,762	1,989	3,293	2,233	1,370	1,464	1,271	653	1,197
Issuance of Common Equity	273	346	333	308	476	68	74	0.00	0.00	-
Other Financing Activities, net	-8.00	-20	-16	452	-20	-29	-19	-15	-32	-12
Cash Interest Paid	611	546	476	779	383	367	387	370	358	335
Cash Income Taxes Paid	-92	-24	-8.00	-23	13	13	21	-19	-12	-15

This table details how cash moves in and out of Ameren's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	48	4.00	23	-80	109	26	-33	42	21	36	7.00
Net Cash From Operating Activities	431	817	897	-35	1,084	533	-160	1,695	496	664	-129
Net Cash From Continuing Operating Activities	431	817	897	-35	1,084	533	-160	1,695	496	664	-129
Net Income / (Loss) Continuing Operations	290	208	457	19	503	159	34	699	265	164	28
Consolidated Net Income / (Loss)	290	208	457	19	503	159	34	699	265	164	28
Depreciation Expense	395	382	382	16	744	369	-321	1,034	350	357	-293
Amortization Expense	25	27	26	3.00	44	16	-17	63	22	23	-14
Non-Cash Adjustments To Reconcile Net Income	-2.00	-19	56	-26	28	-6.00	52	-51	-7.00	-1.00	33
Changes in Operating Assets and Liabilities, net	-277	219	-24	-47	-235	-5.00	92	-50	-134	121	117
Net Cash From Investing Activities	-1,087	-1,350	-1,174	-172	-1,760	-1,142	1,059	-2,751	-964	-912	611
Net Cash From Continuing Investing Activities	-1,087	-1,350	-1,174	-172	-1,760	-1,142	1,059	-2,751	-964	-912	611
Purchase of Property, Plant & Equipment	-1,064	-1,290	-1,137	-163	-1,729	-1,026	1,009	-2,649	-931	-914	606
Purchase of Investments	-107	-85	-176	-183	-140	-110	6.00	-133	-29	-53	68
Sale and/or Maturity of Investments	93	84	171	177	132	104	6.00	113	17	53	-65
Other Investing Activities, net	-9.00	-59	-32	-3.00	-23	-110	38	-82	-21	2.00	2.00
Net Cash From Financing Activities	704	537	300	127	785	635	-932	1,098	489	284	-475
Net Cash From Continuing Financing Activities	704	537	300	127	785	635	-932	1,099	488	288	-479
Repayment of Debt	-300	-75	-514	37	-387	-21	96	-203	-3.00	-73	-450
Repurchase of Common Equity	-11	-	-1.00	-10	-8.00	-	6.00	-13	-5.00	-	1.00
Payment of Dividends	-192	-180	-180	-179	-180	-167	-164	-169	-167	-150	-154
Issuance of Debt	1,207	530	986	268	1,358	493	-882	1,473	678	196	112
Issuance of Common Equity	13	243	9.00	11	10	318	12	11	5.00	304	12
Other Financing Activities, net	-13	-	-	-	-8.00	-	-	-	-20	-	-

This table presents Ameren's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	44,598	40,830	37,904	35,735	32,030	28,933	27,215	25,945	24,699	23,640
Total Current Assets	2,264	2,181	2,668	1,968	1,653	1,431	1,533	1,612	1,593	1,917
Cash & Equivalents	7.00	25	10	8.00	139	16	16	10	9.00	292
Accounts Receivable	871	813	1,100	820	749	734	837	838	795	725
Inventories, net	762	733	667	592	521	494	483	522	527	538
Other Current Assets	528	504	651	540	244	187	197	242	262	348
Plant, Property, & Equipment, net	36,304	33,776	31,262	29,261	26,807	24,376	22,810	21,466	20,113	18,799
Total Noncurrent Assets	6,030	4,873	3,974	4,506	3,159	3,126	2,872	2,867	2,993	2,924
Goodwill	411	411	411	411	-	411	411	411	411	411
Employee Benefit Assets	757	581	411	756	288	-	-	-	-	-
Other Noncurrent Operating Assets	4,862	3,881	3,152	3,339	2,871	2,715	2,461	2,456	2,582	2,513
Total Liabilities & Shareholders' Equity	44,598	40,830	37,904	35,735	32,030	28,933	27,215	25,945	24,699	23,640
Total Liabilities	32,355	29,352	27,267	25,906	22,889	20,732	19,442	18,619	17,454	16,552
Total Current Liabilities	3,413	3,345	3,366	2,826	2,180	2,505	2,687	2,940	2,674	2,093
Short-Term Debt	1,460	1,385	1,410	1,050	498	882	1,177	1,325	1,239	696
Accounts Payable	1,059	1,136	1,159	1,095	958	874	817	902	805	777
Customer Deposits	223	176	115	-	-	0.00	0.00	108	107	100
Other Current Liabilities	475	501	682	681	549	655	693	454	384	359
Other Current Nonoperating Liabilities	196	147	-	-	114	94	-	99	93	118
Total Noncurrent Liabilities	28,942	26,007	23,901	23,080	20,770	18,227	16,755	15,679	14,780	14,459
Long-Term Debt	17,262	15,121	13,685	12,562	11,078	8,915	7,859	7,094	6,595	6,880
Asset Retirement Reserve & Litigation Obligation	6,719	6,284	6,072	6,605	5,978	5,525	5,264	5,025	2,620	2,523
Noncurrent Deferred & Payable Income Tax Liabilities	4,474	4,176	3,804	3,499	3,211	2,919	2,666	2,555	4,319	3,945
Other Noncurrent Operating Liabilities	487	426	340	414	503	467	408	460	477	531
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	12,243	11,478	10,637	9,829	8,938	8,201	7,773	7,326	7,245	7,088
Total Preferred & Common Equity	12,114	11,349	10,508	9,700	8,938	8,059	7,631	7,184	7,103	6,946
Total Common Equity	12,114	11,349	10,508	9,700	8,939	8,059	7,631	7,184	7,103	6,946
Common Stock	7,516	7,219	6,863	6,505	6,182	5,696	5,629	5,542	5,558	5,618
Retained Earnings	4,604	4,136	3,646	3,182	2,757	2,380	2,024	1,660	1,568	1,331
Accumulated Other Comprehensive Income / (Loss)	-6.00	-6.00	-1.00	13	-	-17	-22	-18	-23	-3.00
Noncontrolling Interest	129	129	129	129	-	142	142	142	-	-

This table presents Ameren's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	45,665	44,598	43,298	42,334	41,306	40,830	39,599	38,947	38,064	37,904	37,657
Total Current Assets	2,455	2,264	2,257	2,217	2,084	2,181	2,084	2,019	2,062	2,668	2,518
Cash & Equivalents	23	7.00	17	19	85	25	8.00	7.00	10	10	7.00
Accounts Receivable	1,247	871	1,069	983	861	813	1,022	923	986	1,100	1,093
Inventories, net	669	762	792	740	679	733	760	711	630	667	695
Other Current Assets	516	528	379	475	459	504	294	378	436	651	723
Plant, Property, & Equipment, net	37,010	36,304	35,720	34,873	34,114	33,776	32,938	32,351	31,735	31,262	30,608
Plant, Property & Equipment, gross	37,010	-	-	34,873	34,114	-	-	-	-	-	-
Total Noncurrent Assets	6,200	6,030	5,321	5,244	5,108	4,873	4,577	4,577	4,267	3,974	4,531
Goodwill	411	411	411	411	411	411	411	411	411	411	411
Employee Benefit Assets	765	757	581	566	597	581	470	442	423	411	813
Other Noncurrent Operating Assets	5,024	4,862	4,329	4,267	4,100	3,881	3,696	3,724	3,433	3,152	3,307
Total Liabilities & Shareholders' Equity	45,665	44,598	43,298	42,334	41,306	40,830	39,599	38,947	38,064	37,904	37,657
Total Liabilities	33,317	32,355	31,336	30,666	29,734	29,352	28,427	28,121	27,328	27,267	27,327
Total Current Liabilities	2,863	3,413	3,567	3,293	3,505	3,345	4,017	3,243	2,757	3,366	3,175
Short-Term Debt	1,269	1,460	1,839	1,490	2,017	1,385	2,189	1,679	1,348	1,410	1,376
Accounts Payable	702	1,059	717	774	647	1,136	955	719	664	1,159	820
Customer Deposits	223	223	205	197	190	176	-	-	-	115	-
Current Deferred & Payable Income Tax Liabilities	0.00	-	206	0.00	0.00	-	209	0.00	0.00	-	216
Other Current Liabilities	510	475	600	655	651	501	664	845	745	682	763
Other Current Nonoperating Liabilities	159	196	-	177	-	147	-	-	-	-	-
Total Noncurrent Liabilities	30,454	28,942	27,769	27,373	26,229	26,007	24,410	24,878	24,571	23,901	24,152
Long-Term Debt	18,354	17,262	16,422	16,280	15,167	15,121	13,829	14,328	14,181	13,685	13,577
Asset Retirement Reserve & Litigation Obligation	6,783	6,719	6,360	6,322	6,372	6,284	6,097	6,220	6,164	6,072	6,429
Noncurrent Deferred & Payable Income Tax Liabilities	4,782	4,474	4,477	4,325	4,251	4,176	4,068	3,913	3,856	3,804	3,785
Other Noncurrent Operating Liabilities	535	487	510	446	439	426	416	417	370	340	361
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	12,348	12,243	11,962	11,668	11,572	11,478	11,172	10,826	10,736	10,637	10,330
Total Preferred & Common Equity	12,219	12,114	11,833	11,539	11,443	11,349	11,043	10,697	10,607	10,508	10,201
Preferred Stock	0.00	-	0.00	0.00	0.00	-	-	-	-	-	-
Total Common Equity	12,219	12,114	11,833	11,539	11,443	11,349	11,043	10,697	10,607	10,508	10,201
Common Stock	7,527	7,516	7,267	7,249	7,231	7,219	6,903	6,883	6,864	6,863	6,551
Retained Earnings	4,702	4,604	4,576	4,299	4,219	4,136	4,144	3,817	3,745	3,646	3,636
Accumulated Other Comprehensive Income / (Loss)	-10	-6.00	-10	-9.00	-7.00	-6.00	-4.00	-3.00	-2.00	-1.00	14
Noncontrolling Interest	129	129	129	129	129	129	129	129	129	129	129

This table displays calculated financial ratios and metrics derived from Ameren's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	1.64%	-5.74%	24.44%	10.36%	-1.96%	-6.06%	1.90%	1.61%	-0.36%	0.74%
EBITDA Growth	3.95%	6.94%	-21.70%	55.64%	5.17%	-0.60%	1.70%	4.31%	7.69%	3.53%
EBIT Growth	1.42%	9.48%	13.42%	5.79%	3.87%	-4.25%	-2.47%	5.13%	9.21%	-0.61%
NOPAT Growth	5.33%	3.28%	13.13%	4.22%	6.22%	-1.23%	56.00%	-19.34%	7.72%	1.34%
Net Income Growth	2.59%	7.23%	8.44%	13.46%	5.16%	1.58%	55.20%	-19.73%	3.62%	7.43%
EPS Growth	0.91%	5.80%	7.81%	9.71%	4.48%	0.90%	55.14%	-20.15%	3.47%	7.92%
Operating Cash Flow Growth	7.76%	13.30%	-30.41%	88.30%	-20.41%	0.00%	2.46%	0.05%	4.23%	29.78%
Free Cash Flow Firm Growth	-39.93%	-55.44%	62.14%	-81.11%	-352.85%	-358.41%	2,242.59%	-97.32%	-13.32%	323.46%
Invested Capital Growth	10.92%	9.88%	8.78%	15.50%	12.20%	7.64%	6.06%	4.43%	4.75%	4.35%
Revenue Q/Q Growth	4.42%	-5.40%	6.72%	3.51%	0.21%	-1.71%	0.32%	0.70%	0.80%	-1.01%
EBITDA Q/Q Growth	-29.23%	-28.72%	-26.28%	112.53%	-23.71%	69.98%	56.02%	3.22%	0.64%	1.66%
EBIT Q/Q Growth	-1.48%	1.55%	4.44%	0.20%	2.47%	1.90%	-3.51%	5.87%	0.14%	0.77%
NOPAT Q/Q Growth	3.65%	-1.63%	6.13%	-1.60%	3.21%	0.80%	20.65%	-13.40%	-3.45%	-0.87%
Net Income Q/Q Growth	4.31%	-0.43%	3.65%	1.02%	2.45%	3.22%	18.47%	-14.81%	0.46%	-2.90%
EPS Q/Q Growth	3.76%	-0.45%	3.76%	0.52%	2.34%	3.08%	19.00%	-14.74%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-43.82%	-47.38%	-38.15%	788.52%	-43.47%	-31.85%	92.89%	-3.95%	3.37%	6.67%
Free Cash Flow Firm Q/Q Growth	0.96%	-117.81%	30.44%	15.85%	-71.76%	-5,691.00%	221.76%	-97.04%	6.48%	35.41%
Invested Capital Q/Q Growth	2.82%	3.01%	0.82%	2.01%	4.40%	2.04%	0.68%	0.67%	0.52%	0.81%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	47.92%	46.23%	42.01%	46.78%	49.33%	46.41%	44.43%	45.08%	43.35%	42.59%
EBITDA Margin	46.66%	45.63%	40.22%	63.92%	45.32%	42.25%	39.93%	40.01%	38.97%	36.06%
Operating Margin	19.89%	20.77%	19.04%	20.85%	22.44%	21.44%	21.57%	22.84%	21.76%	20.65%
EBIT Margin	25.36%	25.41%	21.88%	24.01%	25.04%	23.64%	23.19%	24.23%	23.42%	21.37%
Profit (Net Income) Margin	15.57%	15.43%	13.56%	15.56%	15.14%	14.11%	13.05%	8.57%	10.85%	10.43%
Tax Burden Percent	93.46%	86.34%	85.98%	86.37%	84.98%	82.09%	77.60%	47.87%	63.30%	67.09%
Interest Burden Percent	65.70%	70.30%	72.09%	75.05%	71.12%	72.73%	72.52%	73.86%	73.16%	72.76%
Effective Tax Rate	6.54%	13.66%	14.02%	13.63%	15.02%	17.91%	22.40%	52.13%	36.70%	38.29%
Return on Invested Capital (ROIC)	4.80%	5.03%	5.33%	5.27%	5.76%	5.97%	6.45%	4.36%	5.65%	5.48%
ROIC Less NNEP Spread (ROIC-NNEP)	3.50%	3.83%	3.75%	4.01%	3.61%	3.78%	3.81%	2.58%	3.32%	3.52%
Return on Net Nonoperating Assets (RNNOA)	5.21%	5.43%	5.22%	5.34%	4.47%	4.48%	4.42%	2.91%	3.55%	3.64%
Return on Equity (ROE)	10.01%	10.46%	10.54%	10.60%	10.23%	10.44%	10.87%	7.26%	9.20%	9.12%
Cash Return on Invested Capital (CROIC)	-5.56%	-4.39%	-3.09%	-9.12%	-5.74%	-1.39%	0.58%	0.03%	1.01%	1.22%
Operating Return on Assets (OROA)	4.53%	4.84%	4.73%	4.53%	4.76%	4.98%	5.49%	5.91%	5.89%	5.67%
Return on Assets (ROA)	2.78%	2.94%	2.93%	2.94%	2.88%	2.97%	3.09%	2.09%	2.73%	2.77%
Return on Common Equity (ROCE)	9.90%	10.34%	10.41%	10.53%	10.15%	10.26%	10.67%	7.12%	9.01%	8.94%
Return on Equity Simple (ROE_SIMPLE)	9.80%	10.19%	10.27%	10.26%	9.81%	10.35%	10.76%	7.36%	9.28%	9.16%
Net Operating Profit after Tax (NOPAT)	1,417	1,345	1,303	1,151	1,105	1,040	1,053	675	837	777
NOPAT Margin	18.59%	17.94%	16.37%	18.01%	19.07%	17.60%	16.74%	10.93%	13.77%	12.74%
Net Nonoperating Expense Percent (NNEP)	1.30%	1.20%	1.57%	1.25%	2.15%	2.18%	2.65%	1.78%	2.32%	1.96%
Return On Investment Capital (ROIC_SIMPLE)	4.58%	4.81%	5.06%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	52.08%	53.77%	57.99%	53.22%	50.67%	53.59%	55.57%	54.92%	56.65%	57.41%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	28.03%	25.45%	22.97%	25.93%	26.89%	24.97%	22.86%	22.24%	21.59%	21.94%
Earnings before Interest and Taxes (EBIT)	1,933	1,906	1,741	1,535	1,451	1,397	1,459	1,496	1,423	1,303
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3,557	3,422	3,200	4,087	2,626	2,497	2,512	2,470	2,368	2,199
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.90	2.41	3.06	3.28	2.95	3.13	2.73	2.53	2.21	1.80
Price to Tangible Book Value (P/TBV)	3.00	2.50	3.19	3.42	2.95	3.30	2.88	2.68	2.34	1.91
Price to Revenue (P/Rev)	4.61	3.64	4.04	4.97	4.56	4.27	3.31	2.94	2.58	2.04
Price to Earnings (P/E)	29.75	23.71	29.95	32.10	30.32	30.49	25.52	34.74	24.00	19.79
Dividend Yield	3.01%	3.60%	2.83%	2.67%	2.84%	2.84%	3.30%	3.62%	4.05%	4.91%
Earnings Yield	3.36%	4.22%	3.34%	3.12%	3.30%	3.28%	3.92%	2.88%	4.17%	5.05%
Enterprise Value to Invested Capital (EV/IC)	1.74	1.57	1.86	1.94	1.87	1.95	1.78	1.69	1.55	1.36
Enterprise Value to Revenue (EV/Rev)	7.09	5.86	5.95	7.12	6.53	5.95	4.76	4.33	3.87	3.24
Enterprise Value to EBITDA (EV/EBITDA)	15.18	12.83	14.81	11.14	14.41	14.09	11.93	10.82	9.92	8.98
Enterprise Value to EBIT (EV/EBIT)	27.94	23.04	27.22	29.65	26.08	25.18	20.54	17.86	16.51	15.16
Enterprise Value to NOPAT (EV/NOPAT)	38.12	32.65	36.38	39.53	34.26	33.82	28.46	39.58	28.08	25.43
Enterprise Value to Operating Cash Flow (EV/OCF)	19.55	17.13	20.94	14.00	21.91	16.21	13.81	12.62	11.10	9.73
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	318.69	6,657.06	156.76	114.24
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.53	1.44	1.42	1.38	1.30	1.19	1.16	1.15	1.08	1.07
Long-Term Debt to Equity	1.41	1.32	1.29	1.28	1.24	1.09	1.01	0.97	0.91	0.97
Financial Leverage	1.49	1.42	1.39	1.33	1.24	1.18	1.16	1.13	1.07	1.03
Leverage Ratio	3.60	3.56	3.60	3.61	3.56	3.52	3.52	3.48	3.37	3.29
Compound Leverage Factor	2.37	2.50	2.59	2.71	2.53	2.56	2.55	2.57	2.47	2.40
Debt to Total Capital	60.46%	58.98%	58.66%	58.07%	56.43%	54.43%	53.76%	53.47%	51.95%	51.66%
Short-Term Debt to Total Capital	4.72%	4.95%	5.48%	4.48%	2.43%	4.90%	7.00%	8.42%	8.22%	4.75%
Long-Term Debt to Total Capital	55.75%	54.03%	53.18%	53.59%	54.00%	49.53%	46.75%	45.06%	43.74%	46.92%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.42%	0.46%	0.50%	0.55%	0.00%	0.79%	0.84%	0.90%	0.00%	0.00%
Common Equity to Total Capital	39.12%	40.56%	40.84%	41.38%	43.58%	44.78%	45.40%	45.63%	47.11%	47.37%
Debt to EBITDA	5.26	4.82	4.72	3.33	4.41	3.92	3.60	3.41	3.31	3.45
Net Debt to EBITDA	5.26	4.82	4.71	3.33	4.36	3.92	3.59	3.40	3.30	3.31
Long-Term Debt to EBITDA	4.85	4.42	4.28	3.07	4.22	3.57	3.13	2.87	2.79	3.13
Debt to NOPAT	13.21	12.27	11.59	11.82	10.48	9.42	8.58	12.47	9.36	9.75
Net Debt to NOPAT	13.21	12.25	11.58	11.82	10.35	9.40	8.57	12.46	9.35	9.38
Long-Term Debt to NOPAT	12.18	11.24	10.51	10.91	10.03	8.57	7.46	10.51	7.88	8.86
Altman Z-Score	1.08	1.00	1.18	1.15	1.12	1.17	1.10	1.04	1.01	0.96
Noncontrolling Interest Sharing Ratio	1.09%	1.17%	1.26%	0.68%	0.82%	1.78%	1.88%	1.95%	1.98%	2.04%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.66	0.65	0.79	0.70	0.76	0.57	0.57	0.55	0.60	0.92
Quick Ratio	0.26	0.25	0.33	0.29	0.41	0.30	0.32	0.29	0.30	0.49
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,641	-1,173	-754	-1,993	-1,100	-243	94	4.01	150	173
Operating Cash Flow to CapEx	63.97%	71.28%	67.53%	46.95%	53.42%	90.00%	94.93%	99.34%	101.98%	105.95%
Free Cash Flow to Firm to Interest Expense	-2.48	-2.07	-1.55	-5.20	-2.63	-0.64	0.23	0.01	0.39	0.49
Operating Cash Flow to Interest Expense	4.17	4.53	4.66	8.49	4.12	5.70	5.41	5.42	5.54	5.72
Operating Cash Flow Less CapEx to Interest Expense	-2.35	-1.83	-2.24	-9.59	-3.59	-0.63	-0.29	-0.04	0.11	0.32
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.18	0.19	0.22	0.19	0.19	0.21	0.24	0.24	0.25	0.27
Accounts Receivable Turnover	9.05	7.84	8.29	8.15	7.81	7.52	7.51	7.56	7.99	8.16
Inventory Turnover	5.31	5.76	7.33	6.12	5.79	6.48	6.96	6.47	6.46	6.59
Fixed Asset Turnover	0.22	0.23	0.26	0.23	0.23	0.25	0.28	0.30	0.31	0.34
Accounts Payable Turnover	3.62	3.51	4.09	3.32	3.21	3.75	4.07	3.97	4.35	4.71
Days Sales Outstanding (DSO)	40.32	46.55	44.04	44.78	46.71	48.51	48.59	48.27	45.66	44.71
Days Inventory Outstanding (DIO)	68.72	63.35	49.80	59.69	63.09	56.30	52.46	56.46	56.47	55.36
Days Payable Outstanding (DPO)	100.90	103.85	89.15	110.10	113.88	97.44	89.74	91.87	83.88	77.57
Cash Conversion Cycle (CCC)	8.14	6.05	4.68	-5.63	-4.07	7.37	11.32	12.86	18.24	22.51
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	31,058	28,000	25,482	23,425	20,281	18,076	16,793	15,834	15,163	14,476
Invested Capital Turnover	0.26	0.28	0.33	0.29	0.30	0.34	0.39	0.40	0.41	0.43
Increase / (Decrease) in Invested Capital	3,058	2,518	2,057	3,144	2,205	1,283	959	671	687	604
Enterprise Value (EV)	54,010	43,920	47,383	45,512	37,844	35,172	29,964	26,719	23,497	19,754
Market Capitalization	35,166	27,310	32,169	31,779	26,407	25,249	20,802	18,168	15,672	12,470
Book Value per Share	$30.71	$29.06	$27.22	$25.18	$23.85	$21.57	$20.52	$19.41	$19.19	$18.76
Tangible Book Value per Share	$29.67	$28.01	$26.15	$24.12	$23.85	$20.47	$19.42	$18.30	$18.08	$17.65
Total Capital	30,965	27,984	25,732	23,441	20,514	17,998	16,809	15,745	15,079	14,664
Total Debt	18,722	16,506	15,095	13,612	11,576	9,797	9,036	8,419	7,834	7,576
Total Long-Term Debt	17,262	15,121	13,685	12,562	11,078	8,915	7,859	7,094	6,595	6,880
Net Debt	18,715	16,481	15,085	13,604	11,437	9,781	9,020	8,409	7,825	7,284
Capital Expenditures (CapEx)	4,319	3,597	3,351	6,926	3,233	2,411	2,286	2,132	2,076	1,917
Debt-free, Cash-free Net Working Capital (DFCFNWC)	304	196	702	184	-168	-208	7.00	-13	149	228
Debt-free Net Working Capital (DFNWC)	311	221	712	192	-29	-192	23	-3.00	158	520
Net Working Capital (NWC)	-1,149	-1,164	-698	-858	-527	-1,074	-1,154	-1,328	-1,081	-176
Net Nonoperating Expense (NNE)	230	188	224	156	228	206	232	146	178	141
Net Nonoperating Obligations (NNO)	18,815	16,522	14,845	13,596	11,343	9,875	9,020	8,508	7,918	7,388
Total Depreciation and Amortization (D&A)	1,624	1,516	1,459	2,552	1,175	1,100	1,053	974	945	896
Debt-free, Cash-free Net Working Capital to Revenue	3.99%	2.61%	8.82%	2.88%	-2.90%	-3.52%	0.11%	-0.21%	2.45%	3.74%
Debt-free Net Working Capital to Revenue	4.08%	2.95%	8.95%	3.00%	-0.50%	-3.25%	0.37%	-0.05%	2.60%	8.53%
Net Working Capital to Revenue	-15.07%	-15.52%	-8.77%	-13.42%	-9.10%	-18.17%	-18.34%	-21.51%	-17.79%	-2.89%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.43	$4.39	$4.16	$3.86	$3.53	$3.37	$3.34	$2.16	$2.69	$2.60
Adjusted Weighted Average Basic Shares Outstanding	266.80M	262.80M	258.40M	256.30M	247M	245.60M	243.80M	242.60M	242.60M	242.60M
Adjusted Diluted Earnings per Share	$4.42	$4.38	$4.14	$3.84	$3.50	$3.35	$3.32	$2.14	$2.68	$2.59
Adjusted Weighted Average Diluted Shares Outstanding	267.40M	263.40M	259.50M	257.60M	248.70M	247.10M	245.80M	244.20M	243.40M	243.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	397.48M	393.87M	389.60M	385.30M	380.93M	373.81M	372.22M	370.21M	370.21M	370.21M
Normalized Net Operating Profit after Tax (NOPAT)	1,417	1,345	1,303	1,151	1,105	1,040	1,053	987	837	819
Normalized NOPAT Margin	18.59%	17.94%	16.37%	18.01%	19.07%	17.60%	16.74%	15.99%	13.77%	13.44%
Pre Tax Income Margin	16.66%	17.87%	15.77%	18.02%	17.81%	17.19%	16.82%	17.90%	17.13%	15.55%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.92	3.37	3.58	4.01	3.46	3.67	3.64	3.83	3.73	3.67
NOPAT to Interest Expense	2.14	2.38	2.68	3.01	2.64	2.73	2.63	1.73	2.19	2.19
EBIT Less CapEx to Interest Expense	-3.60	-2.99	-3.31	-14.08	-4.25	-2.66	-2.06	-1.63	-1.71	-1.73
NOPAT Less CapEx to Interest Expense	-4.38	-3.98	-4.21	-15.08	-5.08	-3.60	-3.07	-3.73	-3.24	-3.21
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	60.57%	57.65%	57.00%	60.20%	57.01%	57.31%	55.66%	82.61%	64.04%	64.15%
Augmented Payout Ratio	60.57%	57.65%	57.00%	61.51%	57.01%	57.31%	55.66%	87.15%	73.14%	66.04%

This table displays calculated financial ratios and metrics derived from Ameren's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	15.47%	19.96%	5.49%	-3.81%	-11.93%	-20.92%	-10.67%	1.97%	9.74%	32.43%	27.33%
EBITDA Growth	8.47%	-0.68%	190.45%	-67.97%	55.81%	4.84%	7.71%	7.18%	8.10%	-61.91%	-61.96%
EBIT Growth	11.96%	-8.26%	-3.92%	12.90%	7.23%	9.01%	8.83%	10.78%	9.72%	29.84%	11.36%
NOPAT Growth	15.46%	28.65%	-3.29%	10.58%	3.14%	-10.07%	5.43%	7.69%	5.56%	47.21%	11.42%
Net Income Growth	10.69%	30.82%	-7.49%	8.79%	-1.13%	-3.05%	9.05%	14.35%	4.74%	30.16%	6.34%
EPS Growth	9.18%	26.23%	-9.09%	7.78%	-2.00%	-3.17%	7.47%	12.50%	3.09%	31.25%	5.45%
Operating Cash Flow Growth	-12.40%	53.28%	660.63%	-102.06%	118.55%	-19.73%	-24.03%	26.49%	27.84%	-67.77%	-117.06%
Free Cash Flow Firm Growth	-46.27%	-20.78%	-83.07%	-27.32%	-13.42%	-26.62%	24.08%	5.31%	14.36%	38.96%	41.51%
Invested Capital Growth	11.98%	10.92%	11.13%	10.33%	9.20%	9.88%	7.54%	8.99%	8.96%	8.78%	10.07%
Revenue Q/Q Growth	8.04%	-10.68%	28.35%	-6.77%	12.24%	-21.46%	17.05%	-14.65%	0.78%	-11.27%	33.60%
EBITDA Q/Q Growth	27.91%	-33.24%	126.71%	-61.30%	-43.27%	95.23%	-75.00%	88.26%	-62.13%	100.57%	-75.12%
EBIT Q/Q Growth	59.94%	-53.13%	48.06%	0.87%	31.05%	-50.91%	73.97%	-4.20%	33.23%	-50.99%	77.09%
NOPAT Q/Q Growth	34.47%	-47.65%	65.97%	-1.18%	49.84%	-60.65%	89.79%	-7.83%	30.65%	-53.87%	93.86%
Net Income Q/Q Growth	39.42%	-54.49%	75.77%	-0.76%	64.78%	-67.81%	106.69%	-9.81%	61.59%	-63.80%	116.75%
EPS Q/Q Growth	38.96%	-54.71%	75.26%	-1.02%	60.66%	-67.38%	107.78%	-10.00%	58.73%	-63.79%	117.50%
Operating Cash Flow Q/Q Growth	-47.25%	-8.92%	2,662.86%	-103.23%	-63.53%	433.13%	-109.44%	241.73%	-82.55%	614.73%	-109.63%
Free Cash Flow Firm Q/Q Growth	-10.20%	-11.28%	-1.91%	-17.05%	13.00%	-68.66%	29.13%	-4.28%	-1.58%	-1.13%	11.60%
Invested Capital Q/Q Growth	3.38%	2.82%	2.06%	3.23%	2.01%	3.01%	1.33%	2.17%	3.03%	0.82%	2.69%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	44.87%	40.91%	51.73%	51.27%	47.74%	46.42%	54.85%	44.77%	38.70%	35.39%	47.40%
EBITDA Margin	44.59%	37.66%	50.39%	28.53%	68.72%	45.49%	18.30%	85.68%	38.85%	34.31%	15.18%
Operating Margin	20.51%	10.20%	26.97%	21.32%	20.43%	16.32%	29.81%	18.69%	17.02%	13.49%	25.98%
EBIT Margin	24.56%	16.59%	31.62%	27.41%	25.33%	21.69%	34.71%	23.35%	20.81%	15.74%	28.49%
Profit (Net Income) Margin	13.83%	10.72%	21.03%	15.36%	14.43%	9.83%	23.98%	13.58%	12.85%	8.02%	19.64%
Tax Burden Percent	85.29%	137.75%	88.91%	86.96%	85.62%	80.30%	87.74%	86.28%	87.75%	85.42%	85.31%
Interest Burden Percent	66.02%	46.89%	74.82%	64.44%	66.52%	56.41%	78.74%	67.40%	70.40%	59.63%	80.82%
Effective Tax Rate	14.71%	-37.75%	11.09%	13.04%	14.38%	19.70%	12.26%	13.72%	12.25%	14.58%	14.69%
Return on Invested Capital (ROIC)	4.55%	3.63%	6.10%	4.72%	4.62%	3.67%	7.91%	5.13%	4.83%	3.75%	6.85%
ROIC Less NNEP Spread (ROIC-NNEP)	4.13%	3.26%	5.73%	4.41%	4.28%	3.34%	7.62%	4.83%	4.54%	3.24%	6.44%
Return on Net Nonoperating Assets (RNNOA)	6.37%	4.86%	8.48%	6.65%	6.26%	4.73%	10.96%	7.10%	6.52%	4.51%	8.98%
Return on Equity (ROE)	10.92%	8.49%	14.58%	11.37%	10.88%	8.41%	18.87%	12.22%	11.35%	8.26%	15.83%
Cash Return on Invested Capital (CROIC)	-6.48%	-5.56%	-5.77%	-4.91%	-3.86%	-4.39%	-2.05%	-3.40%	-3.33%	-3.09%	-4.50%
Operating Return on Assets (OROA)	4.46%	2.96%	5.57%	4.85%	4.63%	4.13%	7.12%	5.02%	4.56%	3.40%	5.87%
Return on Assets (ROA)	2.51%	1.91%	3.70%	2.72%	2.64%	1.87%	4.92%	2.92%	2.82%	1.73%	4.05%
Return on Common Equity (ROCE)	10.80%	8.39%	14.42%	11.24%	10.75%	8.31%	18.64%	12.07%	11.21%	8.15%	15.63%
Return on Equity Simple (ROE_SIMPLE)	9.94%	0.00%	9.62%	10.18%	10.08%	0.00%	10.52%	10.48%	10.29%	0.00%	10.20%
Net Operating Profit after Tax (NOPAT)	367	273	521	314	318	212	539	284	308	236	511
NOPAT Margin	17.49%	14.05%	23.98%	18.54%	17.49%	13.10%	26.15%	16.13%	14.94%	11.52%	22.16%
Net Nonoperating Expense Percent (NNEP)	0.42%	0.37%	0.37%	0.32%	0.34%	0.34%	0.29%	0.29%	0.29%	0.50%	0.41%
Return On Investment Capital (ROIC_SIMPLE)	1.15%	0.88%	-	-	-	0.76%	-	-	-	0.92%	-
Cost of Revenue to Revenue	55.13%	59.09%	48.27%	48.73%	52.26%	53.58%	45.15%	55.23%	61.30%	64.61%	52.60%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	24.37%	30.71%	24.76%	29.95%	27.31%	30.10%	25.05%	26.08%	21.68%	21.90%	21.42%
Earnings before Interest and Taxes (EBIT)	515	322	687	464	460	351	715	411	429	322	657
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	935	731	1,095	483	1,248	736	377	1,508	801	702	350
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.27	2.90	2.92	2.43	2.52	2.41	2.56	2.88	3.04	3.06	2.88
Price to Tangible Book Value (P/TBV)	3.38	3.00	3.02	2.52	2.62	2.50	2.65	2.99	3.16	3.19	3.00
Price to Revenue (P/Rev)	5.05	4.61	4.73	3.90	3.98	3.64	3.56	3.77	3.96	4.04	3.94
Price to Earnings (P/E)	32.98	29.75	30.44	23.96	25.12	23.71	24.39	27.58	29.71	29.95	28.36
Dividend Yield	2.71%	3.01%	3.02%	3.66%	3.49%	3.60%	3.43%	3.09%	2.90%	2.83%	3.05%
Earnings Yield	3.03%	3.36%	3.28%	4.17%	3.98%	4.22%	4.10%	3.63%	3.37%	3.34%	3.53%
Enterprise Value to Invested Capital (EV/IC)	1.86	1.74	1.75	1.55	1.61	1.57	1.63	1.75	1.83	1.86	1.76
Enterprise Value to Revenue (EV/Rev)	7.55	7.09	7.24	6.39	6.35	5.86	5.59	5.74	5.89	5.95	5.96
Enterprise Value to EBITDA (EV/EBITDA)	16.43	15.18	10.52	10.66	8.64	12.83	9.24	9.83	10.25	14.81	10.24
Enterprise Value to EBIT (EV/EBIT)	30.00	27.94	26.95	23.07	23.79	23.04	23.63	25.79	26.93	27.22	26.67
Enterprise Value to NOPAT (EV/NOPAT)	40.64	38.12	38.67	33.15	34.01	32.65	32.43	35.04	36.34	36.38	36.22
Enterprise Value to Operating Cash Flow (EV/OCF)	22.07	19.55	10.75	11.89	8.24	17.13	9.10	9.57	10.53	20.94	12.15
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.59	1.53	1.53	1.52	1.49	1.44	1.43	1.48	1.45	1.42	1.45
Long-Term Debt to Equity	1.49	1.41	1.37	1.40	1.31	1.32	1.24	1.32	1.32	1.29	1.31
Financial Leverage	1.54	1.49	1.48	1.51	1.46	1.42	1.44	1.47	1.44	1.39	1.39
Leverage Ratio	3.64	3.60	3.58	3.61	3.56	3.56	3.59	3.65	3.59	3.60	3.59
Compound Leverage Factor	2.40	1.69	2.68	2.33	2.37	2.01	2.83	2.46	2.53	2.15	2.90
Debt to Total Capital	61.38%	60.46%	60.42%	60.36%	59.76%	58.98%	58.91%	59.65%	59.12%	58.66%	59.14%
Short-Term Debt to Total Capital	3.97%	4.72%	6.08%	5.06%	7.01%	4.95%	8.05%	6.26%	5.13%	5.48%	5.44%
Long-Term Debt to Total Capital	57.41%	55.75%	54.34%	55.30%	52.74%	54.03%	50.86%	53.40%	53.99%	53.18%	53.70%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.40%	0.42%	0.43%	0.44%	0.45%	0.46%	0.47%	0.48%	0.49%	0.50%	0.51%
Common Equity to Total Capital	38.22%	39.12%	39.15%	39.20%	39.79%	40.56%	40.61%	39.87%	40.38%	40.84%	40.35%
Debt to EBITDA	5.41	5.26	3.63	4.12	3.22	4.82	3.34	3.35	3.32	4.72	3.44
Net Debt to EBITDA	5.40	5.26	3.63	4.12	3.21	4.82	3.33	3.35	3.32	4.71	3.44
Long-Term Debt to EBITDA	5.06	4.85	3.27	3.78	2.84	4.42	2.88	3.00	3.03	4.28	3.13
Debt to NOPAT	13.37	13.21	13.36	12.83	12.68	12.27	11.71	11.96	11.78	11.59	12.18
Net Debt to NOPAT	13.36	13.21	13.35	12.82	12.62	12.25	11.71	11.95	11.77	11.58	12.18
Long-Term Debt to NOPAT	12.51	12.18	12.01	11.76	11.19	11.24	10.11	10.70	10.75	10.51	11.06
Altman Z-Score	1.06	0.96	0.99	0.87	0.90	0.88	0.94	1.00	1.08	1.06	1.01
Noncontrolling Interest Sharing Ratio	1.08%	1.09%	1.12%	1.15%	1.16%	1.17%	1.20%	1.24%	1.25%	1.26%	1.28%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.86	0.66	0.63	0.67	0.59	0.65	0.52	0.62	0.75	0.79	0.79
Quick Ratio	0.44	0.26	0.30	0.30	0.27	0.25	0.26	0.29	0.36	0.33	0.35
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-3,069	-2,785	-2,503	-2,456	-2,098	-2,306	-1,367	-1,929	-1,850	-1,821	-1,801
Operating Cash Flow to CapEx	40.51%	63.33%	78.89%	-21.47%	62.70%	51.95%	0.00%	63.99%	53.28%	72.65%	0.00%
Free Cash Flow to Firm to Interest Expense	-17.54	-16.29	-14.47	-14.89	-13.63	-15.07	-9.00	-14.40	-14.57	-14.01	-14.29
Operating Cash Flow to Interest Expense	2.46	4.78	5.19	-0.21	7.04	3.48	-1.05	12.65	3.91	5.11	-1.02
Operating Cash Flow Less CapEx to Interest Expense	-3.62	-2.77	-1.39	-1.20	-4.19	-3.22	5.59	-7.12	-3.43	-1.92	3.79
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.18	0.18	0.18	0.18	0.18	0.19	0.21	0.21	0.22	0.22	0.21
Accounts Receivable Turnover	7.50	9.05	6.98	7.54	7.85	7.84	7.50	8.50	8.50	8.29	7.27
Inventory Turnover	6.20	5.31	4.76	4.92	5.68	5.76	6.17	7.28	8.30	7.33	6.56
Fixed Asset Turnover	0.22	0.22	0.21	0.21	0.22	0.23	0.25	0.26	0.27	0.26	0.25
Accounts Payable Turnover	6.19	3.62	4.41	4.78	5.67	3.51	5.06	5.90	7.05	4.09	5.19
Days Sales Outstanding (DSO)	48.67	40.32	52.28	48.40	46.47	46.55	48.69	42.93	42.96	44.04	50.20
Days Inventory Outstanding (DIO)	58.90	68.72	76.76	74.16	64.25	63.35	59.17	50.15	43.99	49.80	55.66
Days Payable Outstanding (DPO)	58.94	100.90	82.69	76.30	64.35	103.85	72.18	61.82	51.79	89.15	70.37
Cash Conversion Cycle (CCC)	48.63	8.14	46.34	46.25	46.37	6.05	35.67	31.27	35.15	4.68	35.49
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	32,107	31,058	30,206	29,596	28,671	28,000	27,182	26,826	26,255	25,482	25,276
Invested Capital Turnover	0.26	0.26	0.25	0.25	0.26	0.28	0.30	0.32	0.32	0.33	0.31
Increase / (Decrease) in Invested Capital	3,436	3,058	3,024	2,770	2,416	2,518	1,906	2,213	2,158	2,057	2,312
Enterprise Value (EV)	59,636	54,010	52,867	45,915	46,085	43,920	44,355	46,911	47,915	47,383	44,453
Market Capitalization	39,907	35,166	34,494	28,035	28,857	27,310	28,216	30,782	32,267	32,169	29,378
Book Value per Share	$30.74	$30.71	$30.00	$29.27	$29.05	$29.06	$28.29	$27.42	$27.23	$27.22	$26.43
Tangible Book Value per Share	$29.71	$29.67	$28.96	$28.23	$28.01	$28.01	$27.24	$26.36	$26.17	$26.15	$25.37
Total Capital	31,971	30,965	30,223	29,438	28,756	27,984	27,190	26,833	26,265	25,732	25,283
Total Debt	19,623	18,722	18,261	17,770	17,184	16,506	16,018	16,007	15,529	15,095	14,953
Total Long-Term Debt	18,354	17,262	16,422	16,280	15,167	15,121	13,829	14,328	14,181	13,685	13,577
Net Debt	19,600	18,715	18,244	17,751	17,099	16,481	16,010	16,000	15,519	15,085	14,946
Capital Expenditures (CapEx)	1,064	1,290	1,137	163	1,729	1,026	-1,009	2,649	931	914	-606
Debt-free, Cash-free Net Working Capital (DFCFNWC)	838	304	512	395	511	196	248	448	643	702	712
Debt-free Net Working Capital (DFNWC)	861	311	529	414	596	221	256	455	653	712	719
Net Working Capital (NWC)	-408	-1,149	-1,310	-1,076	-1,421	-1,164	-1,933	-1,224	-695	-698	-657
Net Nonoperating Expense (NNE)	77	65	64	54	56	53	45	45	43	72	58
Net Nonoperating Obligations (NNO)	19,759	18,815	18,244	17,928	17,099	16,522	16,010	16,000	15,519	14,845	14,946
Total Depreciation and Amortization (D&A)	420	409	408	19	788	385	-338	1,097	372	380	-307
Debt-free, Cash-free Net Working Capital to Revenue	10.60%	3.99%	7.01%	5.50%	7.04%	2.61%	3.13%	5.48%	7.90%	8.82%	9.55%
Debt-free Net Working Capital to Revenue	10.89%	4.08%	7.25%	5.76%	8.22%	2.95%	3.23%	5.57%	8.02%	8.95%	9.64%
Net Working Capital to Revenue	-5.16%	-15.07%	-17.95%	-14.97%	-19.59%	-15.52%	-24.38%	-14.97%	-8.54%	-8.77%	-8.81%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.07	$0.77	$1.71	$0.97	$0.98	$0.60	$1.88	$0.90	$1.01	$0.63	$1.75
Adjusted Weighted Average Basic Shares Outstanding	270M	266.80M	266.80M	266.70M	266.40M	262.80M	262.80M	262.60M	262.20M	258.40M	258.40M
Adjusted Diluted Earnings per Share	$1.07	$0.77	$1.70	$0.97	$0.98	$0.61	$1.87	$0.90	$1.00	$0.63	$1.74
Adjusted Weighted Average Diluted Shares Outstanding	271.40M	267.40M	267.30M	266.80M	266.80M	263.40M	263.40M	263.20M	263.10M	259.50M	259.50M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	397.86M	397.48M	394.50M	394.39M	394.25M	393.87M	390.52M	390.33M	390.19M	389.60M	386.10M
Normalized Net Operating Profit after Tax (NOPAT)	367	139	521	314	318	212	539	284	308	236	511
Normalized NOPAT Margin	17.49%	7.14%	23.98%	18.54%	17.49%	13.10%	26.15%	16.13%	14.94%	11.52%	22.16%
Pre Tax Income Margin	16.21%	7.78%	23.65%	17.66%	16.85%	12.24%	27.33%	15.74%	14.65%	9.38%	23.03%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.94	1.88	3.97	2.81	2.99	2.29	4.70	3.07	3.38	2.48	5.21
NOPAT to Interest Expense	2.10	1.60	3.01	1.90	2.06	1.39	3.54	2.12	2.43	1.81	4.06
EBIT Less CapEx to Interest Expense	-3.14	-5.66	-2.60	1.82	-8.24	-4.41	11.34	-16.70	-3.95	-4.55	10.02
NOPAT Less CapEx to Interest Expense	-3.98	-5.95	-3.56	0.91	-9.16	-5.32	10.18	-17.65	-4.91	-5.22	8.87
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	60.25%	60.57%	66.87%	63.40%	63.69%	57.65%	60.33%	61.64%	62.33%	57.00%	61.19%
Augmented Payout Ratio	60.25%	60.57%	67.49%	63.40%	63.95%	57.65%	60.41%	62.18%	62.79%	57.00%	60.81%

Frequently Asked Questions About Ameren's Financials

When does Ameren's financial year end?

According to the most recent income statement we have on file, Ameren's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Ameren's net income changed over the last 9 years?

Ameren's net income appears to be on an upward trend, with a most recent value of $1.19 billion in 2024, rising from $636 million in 2015. The previous period was $1.16 billion in 2023. See where experts think Ameren is headed by visiting Ameren's forecast page.

What is Ameren's operating income?

Ameren's total operating income in 2024 was $1.52 billion, based on the following breakdown:

Total Gross Profit: $3.65 billion
Total Operating Expenses: $2.14 billion

How has Ameren revenue changed over the last 9 years?

Over the last 9 years, Ameren's total revenue changed from $6.10 billion in 2015 to $7.62 billion in 2024, a change of 25.0%.

How much debt does Ameren have?

Ameren's total liabilities were at $32.36 billion at the end of 2024, a 10.2% increase from 2023, and a 95.5% increase since 2015.

How much cash does Ameren have?

In the past 9 years, Ameren's cash and equivalents has ranged from $7 million in 2024 to $292 million in 2015, and is currently $7 million as of their latest financial filing in 2024.

How has Ameren's book value per share changed over the last 9 years?

Over the last 9 years, Ameren's book value per share changed from 18.76 in 2015 to 30.71 in 2024, a change of 63.7%.

Related Companies

This page (NYSE:AEE) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ameren (AEE) Financials

Frequently Asked Questions About Ameren's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ameren (AEE) Financials

Annual Income Statements for Ameren

Quarterly Income Statements for Ameren

Annual Cash Flow Statements for Ameren

Quarterly Cash Flow Statements for Ameren

Annual Balance Sheets for Ameren

Quarterly Balance Sheets for Ameren

Annual Metrics And Ratios for Ameren

Quarterly Metrics And Ratios for Ameren

Frequently Asked Questions About Ameren's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools